TARDBP and lung carcinoma: One recent report proposed a little controversy in the aspect of TDP-43 and apoptosis, and it suggested that TDP-43 restored the sensitiveness of lung cancer cells to cisplatin or lipopolysaccharide by protecting the apoptotic inducer FasL mRNA from decay (86).